Pulmonary Function Testing Systems Market - By Product Type, By Test Type, By Application, By Distribution Channel, By End-use & Forecast, 2023

Description

List of Tables

Global Pulmonary Function Testing Systems Market will witness significant growth from 2023 to 2032. The escalating prevalence of respiratory disorders, spurred by environmental pollutants and lifestyle shifts, necessitates accurate diagnostic tools. According to the American College of Allergy, Asthma, and Immunology, roughly 26.5 million, or 8.4% of Americans, live with asthma.

Similarly, the WHO states COPD is the seventh leading cause of poor health globally.

The growing aging population contributes to the market's expansion as age-related respiratory ailments surge. Technological advancements like portable and user-friendly devices enhance patient compliance and data collection. In addition, the rising awareness about preventive healthcare drives demand for early detection systems. The healthcare infrastructure development in emerging economies broadens accessibility. Collectively, these factors fuel the expansion of the pulmonary function testing systems market size.

The overall Pulmonary Function Testing Systems Market is classified based on product type, test type, application, and region.

Based on the product type, the tabletop segment will drive commendable gains throughout 2023-2032. These systems cater to healthcare facilities seeking efficient diagnostic solutions with limited space. Their user-friendly interfaces enable accurate assessment of respiratory conditions, while the convenience of their tabletop form enhances patient comfort during testing. As the need for precise pulmonary evaluations continues to grow, tabletop systems fulfill a crucial niche, driving their increasing demand in the pulmonary function testing system industry.

By test type, the gas diffusion test segment will strengthen the pulmonary function testing market outlook through 2032. These tests, measuring the diffusion capacity of the lungs, play a crucial role in diagnosing conditions like emphysema and pulmonary fibrosis. As respiratory diseases become more prevalent, the need for accurate and comprehensive diagnostic tools grows. Gas diffusion tests offer valuable insights into lung function, aiding clinicians in early detection and effective management. This escalating demand underscores the significance of gas diffusion test types in shaping the market's trajectory.

Regarding the application, the pulmonary fibrosis segment will contribute significantly to the pulmonary function testing industry revenue over 2023-2032. As this progressive lung disease challenges patients' respiratory capacities, accurate diagnosis and monitoring are paramount. Pulmonary function testing systems play a pivotal role in assessing lung function, aiding in disease management and treatment planning. With pulmonary fibrosis cases on the rise, the market's share is intricately linked to addressing the diagnostic needs of this patient population, highlighting its vital importance.

Regionally, the European Pulmonary Function Testing Systems Market share will grow significantly during the forecast period due to the region's aging population, in line with increasing cases of respiratory diseases. Stringent healthcare standards in countries like Germany, France, and the UK emphasize early disease detection and management, further boosting market demand. Moreover, technological improvements and a proactive approach to healthcare underline Europe's significance in shaping the pulmonary function testing systems market, fostering innovation and improved patient care.

Product Code: 5722

Chapter 1 Methodology & Scope

1.1 Industry coverage
1.2 Market scope & definition
1.3 Base estimates & calculations
- 1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data Sources
- 1.7.1 Primary
- 1.7.2 Secondary
  - 1.7.2.1 Paid sources
  - 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Pulmonary function testing systems industry 360 Degree synopsis, 2018 - 2032
2.2 Business trends
2.3 Regional trends
2.4 Product type trends
2.5 Test type trends
2.6 Application trends
2.7 Distribution channel trends
2.8 End-use trends

Chapter 3 Pulmonary Function Testing Systems Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increase in prevalence of chronic respiratory diseases
  - 3.2.1.2 Technological advancements
  - 3.2.1.3 Increasing popularity of pulmonary function tests
  - 3.2.1.4 Favourable government initiatives
  - 3.2.1.5 Diagnostic advantages in lung testing
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Stringent regulatory framework
  - 3.2.2.2 High cost associated with pulmonary function testing devices
3.3 Growth potential analysis
- 3.3.1 By product type
- 3.3.2 By test type
- 3.3.3 By application
- 3.3.4 By distribution channel
- 3.3.5 By end use
3.4 COVID- 19 impact analysis
3.5 Pricing analysis, 2022
3.6 Regulatory landscape
- 3.6.1 U.S.
- 3.6.2 Europe
3.7 Technology landscape
3.8 Reimbursement scenario
3.9 Future market trends
3.10 Gap analysis
3.11 Porter's analysis
3.12 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Company market share analysis, 2022
4.4 Competitive positioning matrix
4.5 Vendor matrix analysis, 2022
4.6 Strategy dashboard, 2022

Chapter 5 Pulmonary Function Testing Systems Market Size and Forecast, By Product Type (USD Million & Units)

5.1 Key trends, by product type
5.2 Handheld
5.3 Tabletop

Chapter 6 Pulmonary Function Testing Systems Market Size and Forecast, By Test Type (USD Million)

6.1 Key trends, by test type
6.2 Spirometry
6.3 Lung Volume Test
6.4 Gas Diffusion Test
6.5 Exercise Stress Test.
6.6 High Altitude Simulation Testing
6.7 Others

Chapter 7 Pulmonary Function Testing Systems Market Size and Forecast, By Application (USD Million)

7.1 Key trends, by application
7.2 Chronic Obstructive Pulmonary Disease
7.3 Asthma
7.4 Chronic Shortness of Breath
7.5 Pulmonary Fibrosis
7.6 Others

Chapter 8 Pulmonary Function Testing Systems Market Size and Forecast, By Distribution Channel (USD Million)

8.1 Key trends, by distribution channel
8.2 Hospital & clinics pharmacies
8.3 Brick & Mortar
8.4 E-commerce

Chapter 9 Pulmonary Function Testing Systems Market Size and Forecast, By End-use (USD Million)

9.1 Key trends, by end-use
9.2 Hospitals & clinics
9.3 Diagnostic centers
9.4 Homecare settings
9.5 Others

Chapter 10 Pulmonary function testing systems Market Size and Forecast, By Region (USD Million & Units)

10.1 Key trends, by region
10.2 North America
- 10.2.1 U.S.
- 10.2.2 Canada
10.3 Europe
- 10.3.1 Germany
- 10.3.2 UK
- 10.3.3 France
- 10.3.4 Spain
- 10.3.5 Italy
- 10.3.6 Poland
- 10.3.7 Sweden
- 10.3.8 The Netherlands
10.4 Asia Pacific
- 10.4.1 Japan
- 10.4.2 China
- 10.4.3 India
- 10.4.4 Australia
- 10.4.5 South Korea
- 10.4.6 Thailand
- 10.4.7 Indonesia
- 10.4.8 Philippines
10.5 Latin America
- 10.5.1 Brazil
- 10.5.2 Mexico
- 10.5.3 Argentina
- 10.5.4 Colombia
- 10.5.5 Chile
- 10.5.6 Peru
10.6 MEA
- 10.6.1 South Africa
- 10.6.2 Saudi Arabia
- 10.6.3 UAE
- 10.6.4 Israel
- 10.6.5 Turkey
- 10.6.6 Iran

Chapter 11 Company Profiles

11.1 MGC Diagnostics Corporation
11.2 Biomerieux
11.3 CAREstream Medical Ltd
11.4 CHEST M.I.
11.5 COSMED srl
11.6 Ganshorn Medizin Electronic
11.7 Koninklijke Philips N.V.
11.8 Medical Equipment Europe
11.9 Medtronic
11.10 Minato Holdings Inc
11.11 Morgan Scientific Inc.
11.12 ndd Medizintechnik AG
11.13 NSPIRE HEALTH INC
11.14 ResMed Inc.
11.15 SCHILLER
11.16 ThermoFisher Scientific